Pomerantz LLP is investigating Alibaba Group Holding Limited for possible securities fraud and unlawful business practices following reports that Alibaba illicitly accessed an AI model and entered a $600 million non-prosecution agreement with the US Department of Justice for allowing illegal pharmaceuticals sales on its platform. These events caused Alibaba's ADR price to drop significantly. The investigation may lead to a class action lawsuit representing affected investors.
Shares of Alibaba, PDD, and JD.com rose on Friday, with Alibaba leading a 3% gain amid a broader uptick in Chinese internet stocks despite a weak overall market. This move appears driven by sector rotation rather than company-specific news, as Alibab...
Alibaba's stock fell 18% after missing Q1 earnings expectations, but this selloff is seen as overdone, leading to an upgrade to Strong Buy. The company's AI Cloud revenue surged 45% year-over-year, with expectations to maintain over 40% growth and im...
